(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DINGGUI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DINGGUI

ST13

US500000079400932

Class

5

Filing

79400932

Registration

7797649

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

04/03/2026

Trademark type

Combined

Nice classes

5

Filing date

01/25/2024

Registration date

05/20/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/20/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

CN

Examiner

STRUCK, ROBERT J

Law office

L90

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "DINGGUI" in red and outlined in black, yellow, and orange.

Holders and representatives

Holders

YABAO PHARMACEUTICAL GROUP CO., LTD.

Representatives

He Li FIDELI LAW PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Preparations for the treatment of asthma; medical preparations and drugs for the treatment of respiratory system diseases and disorders; medicated lip balm; decoctions for pharmaceutical purposes for the treatment of respiratory system diseases and disorders; medicinal formulations for skin woundspharmaceutical preparations for skin wounds; medicinal formulations for treating bone fracturespharmaceutical preparations for the treatment of bone fractures; paracetamol; anti-inflammatories; antidiarrheal medicines; pharmaceutical preparations for treating asthma; anti-allergy medications; antiviral preparations; pharmaceuticals for treating viral diseases; pharmaceutical preparations for treating allergies; bulk medicine used for treating cardiovascular and cerebrovascular diseases; vitamin supplement tablets; cough suppressant and phlegm relieverscough treatment preparations; injectable medications for allergic reactions; mosquito repellent patch for babies; medicated baby powder; fever reduceribuprofen; antiemetic drugsnausea treatment preparations; cough suppressantscough expectorants; mosquito repellents for use on the skin; preparations for the treatment of heatstroke; anti-inflammatory spray; traditional Chinese medicinal herb preparations; cough drops; pain relief medications; chemotherapeutic drugspharmaceutical preparations for use in chemotherapy; antibiotic for humans; medicated ointment for the treatment of dermatological conditions; ointment for treatment of skin diseases; medicated baby oil; ophthalmic pharmaceutical preparations; migraine treatment preparations; balsamic preparations for medical purposes; cough syrup for medical use; dermatological pharmaceuticals; anti-inflammatory preparations; expectorants; pharmaceutical preparations in the form of tablets for treating cardiovascular and cerebrovascular diseases; disinfectants; fever and pain relieversibuprofen; anticoagulants; anti-inflammatory ointments; oral ibuprofen for pain relief; injectable pharmaceutical preparations for treating cardiovascular and cerebrovascular diseases; injectable dermal fillers; powdered milk for babies; lutein dietary supplements; dietetic foods adapted for medical use; medicated candies; lecithin dietary supplements; mineral dietary supplements; dietetic beverages adapted for medical use; dietetic foods adapted for medical purposes; baby cookiesbaby food; zinc dietary supplement; infant formula; lacteal flour for babies; dietetic beverages adapted for medical purposes; nutritional supplements; candy for pharmaceutical purpose for the treatment of respiratory system diseases and disorders; food for babies; milk sugar for pharmaceutical purposes; dietetic candies adapted for medical purposes; vitamin beverages adapted for medical purposes; casein dietary supplements; liquid formula for infants; linseed oil dietary supplements; protein dietary supplements; disposable baby diapers; baby swim diapers; diaper changing matsdisposablefor babies; disposable swim diapers for toddlers and infants; swim diapersdisposablefor babies; bandages for dressings; medical dressing; adhesive plasters for medical purposes; swim diapersreusablefor babies

Publications

History of USPTO decisions and trademark events.

31 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/08/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/08/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/24/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/24/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/19/2025

FIMP

FINAL DISPOSITION PROCESSED

12/19/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/20/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/20/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/20/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/01/2025

PUBO

PUBLISHED FOR OPPOSITION

04/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/26/2025

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/07/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/07/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

02/21/2025

ALIE

ASSIGNED TO LIE

02/21/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/21/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

02/21/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/21/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/20/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/20/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/20/2025

RFNT

REFUSAL PROCESSED BY IB

09/15/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/26/2024

RFRR

REFUSAL PROCESSED BY MPU

08/26/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/21/2024

CNRT

NON-FINAL ACTION WRITTEN

08/20/2024

DOCK

ASSIGNED TO EXAMINER

08/20/2024

MAFR

APPLICATION FILING RECEIPT MAILED

07/31/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/31/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/25/2024

Continuous trademark protection

Get notified about every new filing that threatens DINGGUI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.